102 related articles for article (PubMed ID: 10579144)
1. Pharmacokinetics of clinafloxacin enantiomers in humans.
Humphrey GH; Shapiro MA; Randinitis EJ; Guttendorf RJ; Brodfuehrer JI
J Clin Pharmacol; 1999 Nov; 39(11):1143-50. PubMed ID: 10579144
[TBL] [Abstract][Full Text] [Related]
2. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetics and bioavailability of clinafloxacin in rats].
Zhou MH; Yu YQ; Duan GL; Cheng WB; Xu CJ; Liu X
Yao Xue Xue Bao; 2001 Feb; 36(2):134-6. PubMed ID: 12579882
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of reboxetine enantiomers in the dog.
Frigerio E; Benecchi A; Brianceschi G; Pellizzoni C; Poggesi I; Strolin Benedetti M; Dostert P
Chirality; 1997; 9(3):303-6. PubMed ID: 9176997
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of levofloxacin in healthy Thai male volunteers.
Chulavatnatol S; Chindavijak B; Vibhagool A; Wananukul W; Sriapha C; Sirisangtragul C
J Med Assoc Thai; 1999 Nov; 82(11):1127-35. PubMed ID: 10659548
[TBL] [Abstract][Full Text] [Related]
6. Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen.
Główka FK; Caldwell J
Chirality; 2002 Oct; 14(9):736-41. PubMed ID: 12237835
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and pharmacodynamic characteristics and safety of inhaled albuterol enantiomers in healthy volunteers.
Gumbhir-Shah K; Kellerman DJ; DeGraw S; Koch P; Jusko WJ
J Clin Pharmacol; 1998 Dec; 38(12):1096-106. PubMed ID: 11301561
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of reboxetine in healthy male volunteers.
Denolle T; Pellizzoni C; Jannuzzo MG; Poggesi I
Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
[TBL] [Abstract][Full Text] [Related]
9. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of prenylamine racemate and enantiomers in man.
Paar WD; Brockmeier D; Hirzebruch M; Schmidt EK; von Unruh GE; Dengler HJ
Arzneimittelforschung; 1990 Jun; 40(6):657-61. PubMed ID: 2397000
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of clinafloxacin after single and multiple doses.
Randinitis EJ; Brodfuehrer JI; Eiseman I; Vassos AB
Antimicrob Agents Chemother; 2001 Sep; 45(9):2529-35. PubMed ID: 11502525
[TBL] [Abstract][Full Text] [Related]
12. The effect of food or sucralfate on the bioavailability of S(+) and R(-) enantiomers of ibuprofen.
Levine MA; Walker SE; Paton TW
J Clin Pharmacol; 1992 Dec; 32(12):1110-4. PubMed ID: 1487549
[TBL] [Abstract][Full Text] [Related]
13. Fasting and postprandial disposition of R(-)- and S(+)-ibuprofen following oral administration of racemic drug in healthy individuals.
Siemon D; de Vries JX; Stötzer F; Walter-Sack I; Dietl R
Eur J Med Res; 1997 May; 2(5):215-9. PubMed ID: 9153347
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
16. The clinical pharmacokinetics of levofloxacin.
Fish DN; Chow AT
Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the enantiomers of felodipine in the dog after oral and intravenous administration of a pseudoracemic mixture.
Eriksson UG; Hoffmann KJ; Simonsson R; Regårdh CG
Xenobiotica; 1991 Jan; 21(1):75-84. PubMed ID: 2003369
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective metabolism and pharmacokinetics of racemic methylphenobarbital in humans.
Lim WH; Hooper WD
Drug Metab Dispos; 1989; 17(2):212-7. PubMed ID: 2565213
[TBL] [Abstract][Full Text] [Related]
19. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.
Verho M; Malerczyk V; Dagrosa E; Korn A
Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
Cao YJ; Smith PF; Wire MB; Lou Y; Lancaster CT; Causon RC; Bigelow GE; Martinez E; Fuchs EJ; Radebaugh C; McCabe S; Hendrix CW
Pharmacotherapy; 2008 Jul; 28(7):863-74. PubMed ID: 18576901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
